CN101822367A - Medicine combination with function of improving nutritional anemia and preparation method thereof - Google Patents

Medicine combination with function of improving nutritional anemia and preparation method thereof Download PDF

Info

Publication number
CN101822367A
CN101822367A CN200910079050A CN200910079050A CN101822367A CN 101822367 A CN101822367 A CN 101822367A CN 200910079050 A CN200910079050 A CN 200910079050A CN 200910079050 A CN200910079050 A CN 200910079050A CN 101822367 A CN101822367 A CN 101822367A
Authority
CN
China
Prior art keywords
cobastab
factor
preparation
vitamin
function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200910079050A
Other languages
Chinese (zh)
Inventor
李仕幸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Increase Pharmaceutical Technology Co Ltd
Original Assignee
Beijing Increase Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Increase Pharmaceutical Technology Co Ltd filed Critical Beijing Increase Pharmaceutical Technology Co Ltd
Priority to CN200910079050A priority Critical patent/CN101822367A/en
Publication of CN101822367A publication Critical patent/CN101822367A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The invention discloses a medicine combination with function of improving nutritional anemia and a preparation method thereof. The medicine combination is prepared by spirulina platensis phycocyanin, vitamin C, vitamin B2 and hemin according to certain weight percent. The medicine combination of the invention has the function of improving nutritional anemia.

Description

A kind of have pharmaceutical composition of improving the alimentary anemia function and preparation method thereof
Technical field
The present invention relates to a kind of pharmaceutical composition of improving the alimentary anemia function and preparation method thereof that has.The invention belongs to field of health care food.
Background technology
Show that according to investigations alimentary anemia is one of human four big nutritive diseases, a series of diseases that caused by anaemia have reduced people's quality of life, brought misery for people's life, and the incidence of disease of countries in the world are all very high.Though improvement along with living condition, people's food quality is significantly improved, but, make that the incidence of disease of alimentary anemia is still high because people are not enough to the knowledge of alimentary anemia understanding, diet structure is unreasonable and most of crowd's partial eclipse, apocleisis, bad life habits such as particular about food.The function of the nutritious and moist whole body of blood, the anaemia or the deficiency of blood can occur that dizzy order flower, sallow complexion, the lazy speech of few food, the withered flesh of hair are dry, extremity numbness etc., severe patient even forgetful, insomnia, symptom such as wandering occur.Therefore prevent alimentary anemia to be even more important.
Summary of the invention
The invention provides a kind of new pharmaceutical composition, said composition has the function of improving alimentary anemia.
Another object of the present invention provides the preparation method of aforementioned pharmaceutical compositions.
The present invention is achieved by the following technical solutions:
The present invention is made by following weight percentages:
Spirulina phycocyanin 5-60%, Catergen-40%, Cobastab 21-10%, X-factor 1-50%.The preferred percentage by weight of described pharmaceutical composition is:
Spirulina phycocyanin 45%, Catergen 0%, Cobastab 25%, X-factor 30%.
Above-mentioned spirulina phycocyanin is commercially available obtaining.
Above-mentioned spirulina phycocyanin, vitamin C, Cobastab 2, X-factor all sieves through 80 eye mesh screens.
The present invention also provides described preparation of drug combination method, it is characterized in that, gets said medicine in proportion, mixes, and adds appropriate amount of auxiliary materials, makes acceptable oral preparation clinically, preferred tablet and capsule.
The present invention also further provides the purposes of described pharmaceutical composition, and this pharmaceutical composition is used to improve alimentary anemia.
Preparation of drug combination method of the present invention is as follows:
Get spirulina phycocyanin, vitamin C, Cobastab in proportion 2, X-factor, mix, add appropriate amount of auxiliary materials, be prepared into acceptable oral preparation clinically, for example capsule, tablet, pill, granule, pill etc.Preferred tablet and capsule formulation.
The preparation method of the preferred tablet of pharmaceutical composition of the present invention is as follows:
Get spirulina phycocyanin, vitamin C, Cobastab in proportion 2, X-factor, mix, adding starch slurry is that adhesive is made particle, cures into dried particle at 60 ℃-70 ℃, makes the lubricant compressing tablet promptly with dolomol again.
The preparation method of pharmaceutical composition preferred capsule of the present invention agent is as follows:
Get spirulina phycocyanin, vitamin C, Cobastab in proportion 2, X-factor, mix, with mixed raw material filled capsules on capsule filling machine; Make Packaging Bottle with the medical plastic bottle and pack, external packing is a carton; Sterilization, check vanning warehouse-in makes product.All under aseptic condition, carry out from preparing burden to packaging process in the production process, when the bacterium inspection exceeds standard, can select ultraviolet ray irradiation or radiation sterilization for use.
In pharmaceutical composition of the present invention, the mechanism of action of each medicine is as follows:
Spirulina phycocyanin: well-known, the content of iron is very high in the spirulina, and iron normally plays a role and promotes function of immune system that important function is arranged for keeping red blood cell.But the iron in the normal food can not effectively be absorbed by human body.Evidence, higher by 60% to the uptake of iron with the spirulina rat feeding than using the ferric sulfate rat feeding.Effective ferro element that high-load is arranged in this explanation spirulina.More Zao test illustrates that also spirulina has better curative effect to the rat anemia.
Vitamin C: claim ascorbic acid again, the ferric iron that it can make human body be difficult to absorb is reduced into ferrous iron, promotes the absorption of enteron aisle to iron, improves the utilization rate of liver to iron, helps to treat hypoferric anemia.Vitamin C can also help iron to transfer on the ferritin from the carrier transferrins.It strengthens the function of some iron enzyme activity in addition in addition.
Cobastab 2: also claiming riboflavin, is the important composition composition of many enzyme systems in the body, the B if body is deficient in vitamin 2, the matter and energy metabolic disorder can appear.Cobastab 2Also be to constitute erythrocytic important substance.Studies have shown that it is to promoting the important effect that is absorbed with of iron.The existing B that is deficient in vitamin that reports 2The pregnant woman hypoferric anemia takes place easily.So appropriate vitamin B 2Picked-up to the prevention status of iron deficiency in pregnant women be highly profitable.
X-factor: can be resolved into protoporphyrin and ferrous iron by the human body epithelial cell, thereby enter the blood utilization that is absorbed by the body, and not have the GI irritation effect.
Below, foregoing of the present invention is described in further detail by the specific embodiment:
Concrete embodiment
Embodiment 1:
Spirulina phycocyanin 45%, Catergen 0%, Cobastab 25%, X-factor 30%, mixes, and adding starch slurry is that adhesive is made particle, cures into dried particle at 60 ℃-70 ℃, makes the lubricant compressing tablet promptly with dolomol again.
Embodiment 2:
Spirulina phycocyanin 50%, Catergen 0%, Cobastab 25%, X-factor 25%, mixes, and adding starch slurry is that adhesive is made particle, cures into dried particle at 60 ℃-70 ℃, makes the lubricant compressing tablet promptly with dolomol again.
Embodiment 3:
Spirulina phycocyanin 45%, Catergen 0%, Cobastab 25%, X-factor 30%, mixes, with mixed raw material filled capsules on capsule filling machine; Make Packaging Bottle with the medical plastic bottle and pack, external packing is a carton; Sterilization, check vanning warehouse-in makes product.All under aseptic condition, carry out from preparing burden to packaging process in the production process, when the bacterium inspection exceeds standard, can select ultraviolet ray irradiation or radiation sterilization for use.
Embodiment 4:
Spirulina phycocyanin 50%, Catergen 0%, Cobastab 25%, X-factor 25%, mixes, with mixed raw material filled capsules on capsule filling machine; Make Packaging Bottle with the medical plastic bottle and pack, external packing is a carton; Sterilization, check vanning warehouse-in makes product.All under aseptic condition, carry out from preparing burden to packaging process in the production process, when the bacterium inspection exceeds standard, can select ultraviolet ray irradiation or radiation sterilization for use.

Claims (6)

1. one kind has pharmaceutical composition that improves the alimentary anemia function and preparation method thereof, it is characterized in that: this pharmaceutical composition is made up of following weight percentages:
Spirulina phycocyanin 5-60%, Catergen-40%, Cobastab 21-10%, X-factor 1-50%.
2. pharmaceutical composition according to claim 1 is characterized in that, the optimum weight percentage of said composition is:
Spirulina phycocyanin 45%, Catergen 0%, Cobastab 25%, X-factor 30%.
3. claim 1 or 2 described preparation of drug combination methods is characterized in that this method is:
Get spirulina phycocyanin, vitamin C, Cobastab in proportion 2, X-factor, mix, add appropriate amount of auxiliary materials, be prepared into acceptable oral preparation clinically, for example capsule, tablet, pill, granule, pill etc.Preferred tablet and capsule formulation.
4. according to the described preparation of drug combination method of claim 3, it is characterized in that this method is:
Get spirulina phycocyanin, vitamin C, Cobastab in proportion 2, X-factor, mix, adding starch slurry is that adhesive is made particle, cures into dried particle at 60 ℃-70 ℃, makes the lubricant compressing tablet promptly with dolomol again.
5. according to the described preparation of drug combination method of claim 3, it is characterized in that this method is:
Get spirulina phycocyanin, vitamin C, Cobastab in proportion 2, X-factor, mix, with mixed raw material filled capsules on capsule filling machine; Make Packaging Bottle with the medical plastic bottle and pack, external packing is a carton; Sterilization, check vanning warehouse-in makes product.All under aseptic condition, carry out from preparing burden to packaging process in the production process, when the bacterium inspection exceeds standard, can select ultraviolet ray irradiation or radiation sterilization for use.
6. claim 1 or 2 described pharmaceutical compositions have the function of improving alimentary anemia.
CN200910079050A 2009-03-04 2009-03-04 Medicine combination with function of improving nutritional anemia and preparation method thereof Pending CN101822367A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910079050A CN101822367A (en) 2009-03-04 2009-03-04 Medicine combination with function of improving nutritional anemia and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200910079050A CN101822367A (en) 2009-03-04 2009-03-04 Medicine combination with function of improving nutritional anemia and preparation method thereof

Publications (1)

Publication Number Publication Date
CN101822367A true CN101822367A (en) 2010-09-08

Family

ID=42686707

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910079050A Pending CN101822367A (en) 2009-03-04 2009-03-04 Medicine combination with function of improving nutritional anemia and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101822367A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102397525A (en) * 2011-11-11 2012-04-04 完美(中国)有限公司 Chinese medicinal composition with function of improving nutritional anemia and preparation method thereof
CN109998114A (en) * 2019-04-03 2019-07-12 江西安顺堂生物科技有限公司 A kind of anti-oxidant, skin whitening, Eradicates spot health care product

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102397525A (en) * 2011-11-11 2012-04-04 完美(中国)有限公司 Chinese medicinal composition with function of improving nutritional anemia and preparation method thereof
CN109998114A (en) * 2019-04-03 2019-07-12 江西安顺堂生物科技有限公司 A kind of anti-oxidant, skin whitening, Eradicates spot health care product

Similar Documents

Publication Publication Date Title
CN103656627B (en) A kind of vitamin C collagen compound effervescent tablet and preparation method thereof
CN100563697C (en) Rhodiola rosea hippophae rhamnoides patch and preparation method thereof
CN101129351A (en) Iron supplement composition, its preparing method and application of the same
CN102349608B (en) Healthcare product combination for clearing and nourishing throat and preparation method thereof
CN103005076A (en) Blood sugar reducing tea and preparation method thereof
CN104206949A (en) Composition for improving osteoporosis and increasing bone mineral density, preparation method of same and application of the same in preparation of health-caring product
CN102349963A (en) Health care product for preventing microthrombus from forming and preparation method thereof
CN104432063B (en) Composition for alleviating athletic fatigue and preparation method thereof
CN102379415A (en) Antioxidant healthcare capsule and preparation method thereof
CN102847159A (en) A glucose metabolism enhancer
CN101822367A (en) Medicine combination with function of improving nutritional anemia and preparation method thereof
CN103156107A (en) Inulin-spirulina compound tablet and preparation method thereof
CN103652939B (en) Capsule with multiple vitamins C
CN105410941A (en) Serene Tablet health-care food capable of increasing bone density and strengthening immunity and preparation method thereof
CN109010514A (en) Composition, health care product and the preparation method of altitude sickness prevention
CN106942728A (en) A kind of clover barley product and its preparation method and application
CN100506085C (en) Brown sugar health product capable of raising immunity of puerpera
CN103877115A (en) Compound vitamin composition, and pharmaceutical preparation and application thereof
CN108323762B (en) Selenium-rich composition and preparation, preparation method and application thereof
CN101869609B (en) Qi-blood tonifying medicament and preparation method and application thereof
CN104872650A (en) Tablets containing multiple vitamins and mineral substances suitable for children and teenagers
CN102948663A (en) Rana japonica oil granules and preparation method thereof
CN100423773C (en) Application of edestin in preparation of medicament
CN102614235A (en) Acanthopanax root tea paste and preparation method thereof
CN103961404A (en) Health-care composition and health-care product

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20100908